These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6602641)

  • 1. E-rosette inhibition and tumour recurrence in early breast cancer.
    Haffejee AA; Webster DJ; Paterson AG; Whitehead RH; Thatcher J; Hughes LE; Angorn IB
    Br J Surg; 1983 Jun; 70(6):319-21. PubMed ID: 6602641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of 'high affinity' T-cell rosettes indicative of recurrent carcinoma.
    Weese J; West W; Herberman R; Turcotte JG
    Surg Forum; 1977; 28():155-7. PubMed ID: 310169
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
    Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
    Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
    Das SN; Khanna NN; Khanna S
    Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy.
    Osborne MP; Borgen PI; Wong GY; Rosen PP; McCormick B
    Surg Gynecol Obstet; 1992 Mar; 174(3):189-94. PubMed ID: 1542833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of time to death after distant recurrence in breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease.
    Ramey WG; Hashim GA; Fitzpatrick HF
    Br J Surg; 1979 Dec; 66(12):848-52. PubMed ID: 315807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrence risk after previous salvage mastectomy.
    Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
    Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CA 15-3 serum levels in breast cancer patients.
    Skrzydlewski Z; Niklinski J; Kiluk S; Kiluk M; Musiatowicz B; Zaremba E; Skrzydlewska E; Klepacki A
    Minerva Chir; 1997 Mar; 52(3):251-4. PubMed ID: 9099053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
    Lopez M; O'Connor R; MacFarlane JK; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence after simple mastectomy.
    O'Rourke S; Galea MH; Morgan D; Euhus D; Pinder S; Ellis IO; Elston CW; Blamey RW
    Br J Surg; 1994 Mar; 81(3):386-9. PubMed ID: 8173907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation versus immunity in early breast cancer.
    Turnbull AR; Turner DT; Jones BM; Wright R
    Clin Oncol; 1979 Sep; 5(3):237-44. PubMed ID: 315295
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effect of postoperative irradiation on the immune functions in patients with mammary carcinoma.
    Toivanen A; Nordman E
    Acta Radiol Oncol; 1981; 20(2):119-24. PubMed ID: 6270963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour bed positivity predicts outcome after breast-conserving surgery.
    Macmillan RD; Purushotham AD; Mallon E; Love JG; George WD
    Br J Surg; 1997 Nov; 84(11):1559-62. PubMed ID: 9393279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer.
    Kim HJ; Kwak JY; Choi JW; Bae JH; Shin KM; Lee HJ; Kim GC; Jung JH; Park JY
    Ann Surg Oncol; 2010 Oct; 17(10):2670-6. PubMed ID: 20422455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
    Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
    Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the mechanism of T-cell depression following radiotherapy or surgery for stage III breast cancer.
    Shukla HS; Whitehead RH; Hughes LE
    Clin Oncol; 1980 Mar; 6(1):39-47. PubMed ID: 6966205
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.
    Mackay IR; Goodyear MD; Riglar C; Penschow J; Whittingham S; Russell IS; Kitchen PR; Collins JP
    Cancer; 1984 Jun; 53(12):2619-27. PubMed ID: 6609758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
    Adler A; Stein JA; Ben-Efraim S
    Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.